Ayr Wellness Inc. (OTCMKTS:AYRWF - Free Report) - Ventum Cap Mkts issued their FY2026 EPS estimates for Ayr Wellness in a report issued on Wednesday, November 13th. Ventum Cap Mkts analyst J. Zandberg expects that the company will post earnings per share of ($0.73) for the year. The consensus estimate for Ayr Wellness' current full-year earnings is ($1.19) per share.
Several other brokerages also recently commented on AYRWF. Atb Cap Markets downgraded shares of Ayr Wellness from a "hold" rating to a "strong sell" rating in a research report on Wednesday. Roth Capital upgraded Ayr Wellness to a "strong-buy" rating in a research note on Friday, November 8th. Finally, Roth Mkm reduced their price objective on Ayr Wellness from $3.50 to $3.00 and set a "buy" rating on the stock in a research note on Thursday.
View Our Latest Stock Report on AYRWF
Ayr Wellness Price Performance
Shares of AYRWF traded down $0.01 during trading hours on Friday, hitting $0.77. 353,810 shares of the company were exchanged, compared to its average volume of 292,592. The firm's fifty day moving average is $1.84 and its 200 day moving average is $2.01. Ayr Wellness has a fifty-two week low of $0.71 and a fifty-two week high of $4.09. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.67 and a current ratio of 1.75.
Ayr Wellness Company Profile
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Recommended Stories
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
